Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry M Lever

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The American Journal of Cardiology|April 2, 2003
Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomyMarta Sitges, Takahiro Shiota, Harry M Lever, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 8, 2017
Why we need more septal myectomy surgeons: An emerging recognitionBarry J Maron, Joseph A Dearani, Martin S Maron, et al.
Journal of the American College of Cardiology|September 12, 2015
Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic ObstructionBarry J Maron, Joseph A Dearani, Steve R Ommen, et al.
The American Journal of Cardiology|August 14, 2022
Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert PanelBarry J Maron, Joseph A Dearani, Nicholas G Smedira, et al.
Circulation. Heart Failure|March 31, 2023
Transforming Growth Factor-β Analysis of the VANISH Trial CohortYuri Kim, Mitra Mastali, Jennifer E Van Eyk, et al.
Nature Medicine|September 24, 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y Ho, Sharlene M Day, Anna Axelsson, et al.
JAMA Cardiology|September 6, 2023
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical TrialChristoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The American Journal of Cardiology|April 2, 2003
Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomyMarta Sitges, Takahiro Shiota, Harry M Lever, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 8, 2017
Why we need more septal myectomy surgeons: An emerging recognitionBarry J Maron, Joseph A Dearani, Martin S Maron, et al.
Journal of the American College of Cardiology|September 12, 2015
Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic ObstructionBarry J Maron, Joseph A Dearani, Steve R Ommen, et al.
The American Journal of Cardiology|August 14, 2022
Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert PanelBarry J Maron, Joseph A Dearani, Nicholas G Smedira, et al.
Circulation. Heart Failure|March 31, 2023
Transforming Growth Factor-β Analysis of the VANISH Trial CohortYuri Kim, Mitra Mastali, Jennifer E Van Eyk, et al.
Nature Medicine|September 24, 2021
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y Ho, Sharlene M Day, Anna Axelsson, et al.
JAMA Cardiology|September 6, 2023
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical TrialChristoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, et al.
Pageof 7